|
⚲
|
| Keyboard |
| DAFNA Capital Management LLC
✚
|
|
|---|---|
| CRD # | 129053 |
| SEC # | 801-62559 |
| CIK # | 0001389933 |
| AUM | 645.2 M (2026-03-30) |
| Employees | 8 (88% Investors, 0% Brokers) |
| Phone | 310-954-3200 |
| Address | 10990 Wilshire Boulevard Los Angeles, CA 90024 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Revolution Medicines Inc | 56.5 | ||
| Stereotaxis Inc | 25.2 | ||
| AtriCure Inc | 17.0 | ||
| IDEAYA Biosciences Inc | 15.9 | ||
| Xenon Pharmaceuticals Inc | 14.6 | ||
| Cytokinetics Inc | 14.3 | ||
| Compass Pathways PLC | 13.4 | ||
| Nektar Therapeutics | 11.9 | ||
| Arcus Biosciences Inc | 9.6 | ||
| Neurocrine Biosciences Inc | 9.3 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | DAFNA Fund LP Series A | [2012-03-29] | 92.5 M | 262.3 M |
| HF | DAFNA Fund LP Series B | [2012-03-29] | 92.5 M | 0.5 M |
| HF | DAFNA Fund LP Series C | [2012-03-29] | 92.5 M | 169.8 M |
| HF | DAFNA International Fund Ltd Class A | 2012-03-29 | 160.5 M | |
| HF | DAFNA International Fund Ltd Class B | 2012-03-29 | ||
| HF | DAFNA International Fund Ltd Class C | 2012-03-29 | 43.6 M | |
| HF | DAFNA Lifescience LP | 2012-03-29 | 431.7 M | |
| HF | DAFNA Lifescience Market Neutral LP | 2012-03-29 | 0.5 M | |
| HF | DAFNA Lifescience Select LP | 2012-03-29 | 213.5 M |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 4 | 645.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 4 | 645.2 |
| By Discretionary | ||
| Discretionary | 4 | 645.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 4 | 645.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 204.2 | |
| United States Persons | 441.1 | |
| Total | 4 | 645.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Nathan Fischel | 3 | 2 | ||
| Fariba Ghodsian | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001389933] | |
| 3 | [0001389933] | |
| SC 13D | [0001389933] | |
| SC 13G | [0001389933] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.1B |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 254900W3EEPXDZYS3V12 |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Stereotaxis, Inc. | |
| DAFNA Capital Management LLC | |
| Ghodsian Fariba Fischel |
| Comparable Firms | State | AUM |
|---|---|---|
|
Goodlander Investment Management LLC
✚
|
TX | 660.5 M |
|
Polar Capital America Corporation
✚
|
FL | 656.1 M |
|
Rings Capital Management LLC
✚
|
IL | 653.0 M |
|
OCO Capital Partners LP
✚
|
NY | 651.8 M |
|
Guardian Point Capital LP
✚
|
VA | 646.4 M |
|
Karya Capital Management LLC
✚
|
NY | 643.5 M |
|
Jones Hill Capital LP
✚
|
NY | 642.4 M |
|
Stanley Capital Management LLC
✚
|
TX | 634.6 M |
|
Simcoe Capital Management LLC
✚
|
NY | 633.8 M |
|
G2 Investment Partners Management LLC
✚
|
NY | 630.2 M |